Freedom Wealth Alliance’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
RJFSA
Freedom Wealth Alliance's ARKG Position: Q1 2023 in Review
Freedom Wealth Alliance sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 150 shares — an estimated $4.24K sold.
Freedom Wealth Alliance first reported a position in ARKG in Q4 2022 and held it in 1 quarter. The position peaked at $4.24K in Q4 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.
- Freedom Wealth Alliance reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
- Freedom Wealth Alliance sold 150 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $4.24K.
- Freedom Wealth Alliance first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 1 quarter.
- Freedom Wealth Alliance's ARK Genomic Revolution ETF position peaked at $4.24K in Q4 2022.
- 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.
Based on Freedom Wealth Alliance's 13F filing for Q1 2023, filed 25 Apr 2023.